Content area

|
|

Indikationen for behandling med warfarin bør altid fremgå eksplicit ved sektorskifte

Anførelse af behandlingsindikation kunne med fordel føjes til Sundhedsstyrelsens anbefalinger for antikoagulansbehandling.
Forfatter(e)
Thea Vestergaard1, Johanne Hjort2, Henrik Bjørnsgaard Madsen1, Jonas Agerlund Povlsen1, 2 & Bo Løfgren1, 2, 3 1) Medicinsk Afdeling, Regionshospitalet Randers 2) Institut for Klinisk Medicin, Aarhus Universitet 3) Center for Akutforskning, Aarhus Universitetshospital Ugeskr Læger 2014;176:V07140399
Reference: 
Ugeskr Læger 2014;176:V07140399
Blad nummer: 
Sidetal: 
2-3
Speciale: 
Indication of treatment with Warfarin should be stated explicitly
Warfarin has a narrow therapeutic window and side effects include bleeding causing e.g. hospital admission and death. Monitoring of treatment and review of indication are mandatory. We report a case of more than four years of warfarin treatment without indication. Treatment was not discontinued due to inadequate medical record keeping and communication among healthcare providers. Medical-record keeping should follow guidelines from the National Board of Health. In addition, clearly stated treatment duration and indication may prevent unwarranted or premature termination of treatment.
Du skal være logget ind for at læse denne artikel
Log ind

Right side